HUP9900851A2 - Benzotiofénszármazékok felhasználása véredény simaizom sejtek migrálásának inhibiálására alkalmas gyógyszerkészítmények előállítására - Google Patents

Benzotiofénszármazékok felhasználása véredény simaizom sejtek migrálásának inhibiálására alkalmas gyógyszerkészítmények előállítására

Info

Publication number
HUP9900851A2
HUP9900851A2 HU9900851A HUP9900851A HUP9900851A2 HU P9900851 A2 HUP9900851 A2 HU P9900851A2 HU 9900851 A HU9900851 A HU 9900851A HU P9900851 A HUP9900851 A HU P9900851A HU P9900851 A2 HUP9900851 A2 HU P9900851A2
Authority
HU
Hungary
Prior art keywords
powder
smooth muscle
cell migration
muscle cell
vascular smooth
Prior art date
Application number
HU9900851A
Other languages
English (en)
Inventor
Jai P. Singh
Todd R. Wiernicki
Original Assignee
Eli Lilly And Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co. filed Critical Eli Lilly And Co.
Publication of HUP9900851A2 publication Critical patent/HUP9900851A2/hu
Publication of HUP9900851A3 publication Critical patent/HUP9900851A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány tárgya eljárás gyógyszerkészítmény előállításárasimaizőmsejt-migrálás inhibiálására. A találmány szerinti készítményaz (I) általánős képletű vegyület vagy gyógyszerészetileg elfőgadhatósója vagy szőlvátja hatásős mennyiségét tartalmazza, ahől az általánősképletben R1 és R3 jelentése egymástól függetlenül hidrőgénatőm,metilcsőpőrt, -C(O)-(1-6 szénatőmős alkil)-csőpőrt, vagy -C(O)-Arképletű csőpőrt, ahől Ar jelentése kívánt esetben szűbsztitűáltfenilcsőpőrt, R2 jelentése pirrőlidinőcsőpőrt, hexametilén-iminő-csőpőrt vagy piperidinőcsőpőrt. A készítmények érrendszeriszövődmények kezelésére alkal- masak. ŕ
HU9900851A 1995-06-01 1996-05-30 Use of benzotiophene derivatives for producing pharmaceuticals for inhibiting vascular smooth muscle cell migration HUP9900851A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/457,700 US5622975A (en) 1995-06-01 1995-06-01 Methods for inhibiting vascular smooth muscle cell migration

Publications (2)

Publication Number Publication Date
HUP9900851A2 true HUP9900851A2 (hu) 1999-09-28
HUP9900851A3 HUP9900851A3 (en) 1999-11-29

Family

ID=23817780

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900851A HUP9900851A3 (en) 1995-06-01 1996-05-30 Use of benzotiophene derivatives for producing pharmaceuticals for inhibiting vascular smooth muscle cell migration

Country Status (20)

Country Link
US (1) US5622975A (hu)
EP (1) EP0745384A3 (hu)
JP (1) JPH11509836A (hu)
KR (1) KR19990022053A (hu)
CN (1) CN1089237C (hu)
AU (1) AU707756B2 (hu)
CA (1) CA2222292A1 (hu)
CZ (1) CZ287958B6 (hu)
EA (1) EA000190B1 (hu)
HU (1) HUP9900851A3 (hu)
IL (1) IL118483A (hu)
MY (1) MY112973A (hu)
NO (1) NO975369D0 (hu)
NZ (1) NZ309390A (hu)
PL (1) PL323786A1 (hu)
RO (1) RO117996B1 (hu)
UA (1) UA42835C2 (hu)
WO (1) WO1996038145A1 (hu)
YU (1) YU32196A (hu)
ZA (1) ZA964439B (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5770609A (en) 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
WO1996040098A2 (en) 1995-06-07 1996-12-19 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
US5843974A (en) * 1995-06-06 1998-12-01 Eli Lilly And Company Methods of inhibiting melanoma using Benzothiophenes as cytotoxic agents per se
US5811437A (en) * 1996-05-21 1998-09-22 Eli Lilly And Company Methods of increasing nitric oxide synthesis
US5747509A (en) * 1996-06-03 1998-05-05 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)
US6124260A (en) * 1998-09-30 2000-09-26 Cedars-Sinai Medical Center Inhibition of smooth muscle cell migration by Tenascin-C peptides
ES2246234T3 (es) 1999-05-04 2006-02-16 Strakan International Limited Glicosidos de androgenos y actividad androgenica de los mismos.
US6776796B2 (en) 2000-05-12 2004-08-17 Cordis Corportation Antiinflammatory drug and delivery device
US20040243097A1 (en) * 2000-05-12 2004-12-02 Robert Falotico Antiproliferative drug and delivery device
US8236048B2 (en) * 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
US20020111590A1 (en) * 2000-09-29 2002-08-15 Davila Luis A. Medical devices, drug coatings and methods for maintaining the drug coatings thereon
AU2001294869B2 (en) 2000-09-29 2006-06-15 Cardinal Health 529, Llc Coated medical devices
US20020051730A1 (en) * 2000-09-29 2002-05-02 Stanko Bodnar Coated medical devices and sterilization thereof
US7195640B2 (en) * 2001-09-25 2007-03-27 Cordis Corporation Coated medical devices for the treatment of vulnerable plaque
US7108701B2 (en) * 2001-09-28 2006-09-19 Ethicon, Inc. Drug releasing anastomosis devices and methods for treating anastomotic sites
US20030065377A1 (en) * 2001-09-28 2003-04-03 Davila Luis A. Coated medical devices
JP3887588B2 (ja) * 2002-08-30 2007-02-28 株式会社リガク Ｘ線回折による応力測定法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4656187A (en) * 1981-08-03 1987-04-07 Eli Lilly And Company Treatment of mammary cancer
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5457113A (en) * 1993-10-15 1995-10-10 Eli Lilly And Company Methods for inhibiting vascular smooth muscle cell proliferation and restinosis
IL112034A (en) * 1993-12-21 1999-03-12 Lilly Co Eli Use of raloxifene and related compounds in the preparation of medicaments useful for the inhibition of ldl oxidation and atherosclerosis

Also Published As

Publication number Publication date
ZA964439B (en) 1997-12-01
HUP9900851A3 (en) 1999-11-29
NO975369L (no) 1997-11-21
CZ287958B6 (cs) 2001-03-14
CA2222292A1 (en) 1996-12-05
IL118483A (en) 2000-06-29
EP0745384A3 (en) 1997-02-26
WO1996038145A1 (en) 1996-12-05
JPH11509836A (ja) 1999-08-31
CN1191487A (zh) 1998-08-26
US5622975A (en) 1997-04-22
RO117996B1 (ro) 2002-12-30
YU32196A (sh) 1999-06-15
CZ374497A3 (cs) 1998-06-17
MY112973A (en) 2001-10-31
CN1089237C (zh) 2002-08-21
EA000190B1 (ru) 1998-12-24
AU5954196A (en) 1996-12-18
AU707756B2 (en) 1999-07-22
EP0745384A2 (en) 1996-12-04
KR19990022053A (ko) 1999-03-25
EA199700450A1 (ru) 1998-06-25
UA42835C2 (uk) 2001-11-15
NZ309390A (en) 2000-07-28
IL118483A0 (en) 1996-09-12
PL323786A1 (en) 1998-04-27
NO975369D0 (no) 1997-11-21
MX9709189A (es) 1998-03-31

Similar Documents

Publication Publication Date Title
HUP9900851A2 (hu) Benzotiofénszármazékok felhasználása véredény simaizom sejtek migrálásának inhibiálására alkalmas gyógyszerkészítmények előállítására
HUP9600448A2 (hu) Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk
CA2316902A1 (en) Alpha-aminoamide derivatives useful as analgesic agents
EP1070710A3 (en) Dithiolan derivatives, their preparation and their therapeutic effect
IE871733L (en) Amides
ATE127801T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung.
CA2107014A1 (en) Therapeutic Agent for Parkinson's Disease
TW369535B (en) A pyrazolopyridine compound and the process for preparing thereof
JO1351B1 (en) Chemical compounds
HUP9702345A2 (hu) 3-Hidroxi-piridin-2-karbonsav-amid-észter-származékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk
TW375615B (en) Galanthamine derivatives and their use as medicaments
ES8503686A1 (es) Procedimiento de preparar derivados de penicilina.
KR920006360A (ko) 스쿠알렌 합성효소 억제제
ES8606330A1 (es) Procedimiento para preparar derivados de acidos quinolincar-boxilicos
BG103207A (en) Esters of the arylcycloalkanecarboxylic acids, their application, pharmaceutical compositions and their preparation
ATE81655T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung.
ATE19773T1 (de) Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung.
HUP9701660A2 (hu) 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények
HUP9901212A2 (hu) N,N-dialkil-N-[2-(3-alkoxi-fenoxi)-etil]-amin-származékok, az ezeket tartalmazó gyógyszerkészítmények és helyi érzéstelenítőkként való alkalmazásuk
HUP9900911A1 (hu) Gyógyászatilag hatásos zsírsavszármazékok, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények
AU1466295A (en) Amino acid derivatives and their use as phospholipase a2 inhibitors
RU94044357A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования увеличения веса, индуцирования снижения веса или ингибирования аппетита
HUP9800550A2 (hu) Benzotiofénszármazékok alkalmazása környezeti ösztrogének inhibiálására szolgáló gyógyszerkészítmények előállítására
HUP9903526A2 (hu) Pirimidinszármazékok és az ezeket tartalmazó gyógyszerkészítmények
HUP0003475A2 (hu) Neutrofil-elasztáz gátló hatású pirrolo-pirrolon-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények